About Us
NEXGEN Formulations, a growing pharmaceutical organization provides general formulations, ophthalmic brands and critical care injectable antibiotics at an affordable cost. Our well qualified staff and workforce are motivated to reach higher goals for their individual development and for the betterment of the company.
Our mission is to deliver trusted, high-quality, and affordable pharmaceutical solutions that improve health outcomes and enhance quality of life. We are dedicated to continuous innovation and excellence ensuring that every product we develop meets the highest standards of safety, efficacy, and care. We strive to: Empower healthcare professionals with dependable and effective therapeutic options. Continuously advance through research, innovation, and technology. Uphold ethical practices and quality assurance at every stage of production. Strengthen our presence across markets while maintaining patient-centric values. By combining science with compassion, our mission is to make a meaningful difference in global healthcare — one patient, one product, and one innovation at a time.
What Sets us Apart
We stand apart through our unwavering commitment to quality, innovation, and trust — values that define every division of our organization. Our strength lies not only in producing world-class medicines but also in the purpose that drives us: advancing healthcare with responsibility and precision.
- Diverse Expertise: From General Medicine to Ophthalmic, Critical Injectables, Gynaecology, and Orthopaedic care, our multi-specialty focus ensures comprehensive healthcare solutions under one roof.
- Uncompromised Quality: Every formulation undergoes stringent testing and validation to ensure safety, purity, and efficacy.
- Innovation-Driven: We invest continuously in R&D to develop advanced, patient-centric therapies aligned with evolving medical needs.
- Ethical Excellence: Transparency, integrity, and regulatory compliance form the foundation of our operations.
- Global Vision, Local Care: We combine global standards with an understanding of local healthcare needs, delivering accessible and reliable products worldwide.
Storyline
- 2016
Our journey started with Nexgen Formulations.
- 2018
Critical care injectables brand XENOVA was launched.
- 2020
OPTICARE, an ophthalmic division was started.
- 2022
Orthopaedic division, ATS launched.
